WOONSOCKET, R.I., July 29, 2025 /PRNewswire/ -- To make the health care system easier to navigate, Aetna, a CVS Health® company (NYSE: CVS), today announced the introduction of Aetna Care Paths and AI-driven programs as part of the company's ongoing technology investment to improve the experience for medical professionals and their patients.
Aetna Care Paths is a new digital offering available to members through the Aetna Health app. This technology simplifies the member experience by giving clarity about procedures and benefits that may be encountered and personalized care recommendations, all in one convenient location. At the core of Aetna Care Paths is a US patent-pending technology that delivers personalized recommendations for programs that will support members on their healthcare journey.
With Aetna Care Paths, members with certain health conditions receive a personalized view of their relevant benefit information as well as a care team to support them throughout their journey. Through AI-powered technology, members will find personalized health and wellness programs tailored to their specific condition, as well as the opportunities to order care kits for additional support.
Aetna Care Paths is a marked shift from the transactional approach to health care taken by most insurance companies, to one that is journey-based and holistic.
"Aetna Care Paths are one example of CVS Health's $20 billion multi-year digital investment in making health care simpler to navigate, a key aspect of Aetna's strategy of leveraging technology to deliver a better experience for our members and providers," said Nathan Frank, Senior Vice President and Chief Digital and Technology Officer at Aetna. "Leading-edge digital tools, including AI, support members at every stage of their health journey."
Nearly half of active Aetna members turn to the app each month to understand their benefits, manage their health and search for health care providers. Aetna Care Paths is just one of many tools that members can access through the Aetna App. Recent updates to the app include:
Learn more about the Aetna Health app's capabilities.
As we help members achieve their health goals more rapidly, we also save time for our colleagues. AI-driven clinical care summaries are a unique innovation aimed at giving nurses more time – as much as 90 minutes per day, or a full day per week – to engage and support members.
"We're giving our nurses more quality time to connect with members, listen to their concerns and help them navigate their health journeys," said Dr. Ben Kornitzer, Aetna's Chief Medical Officer. "This could be a cancer patient, or a member recently diagnosed with heart disease, and that extra time in one-on-one conversations not only improves physical health outcomes but also supports our member's mental well-being. Helping our members achieve their best health, is our number one priority."
Other new Aetna technology solutions include:
CVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of March 31, 2025, the Company had more than 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics, a leading pharmacy benefits manager with approximately 88 million plan members, and a dedicated senior pharmacy care business serving more than 800,000 patients per year. The Company also serves an estimated more than 37 million people through traditional, voluntary and consumer-directed health insurance products and related services, including highly rated Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company's integrated model uses personalized, technology driven services to connect people to simply better health, increasing access to quality care, delivering better outcomes, and lowering overall costs.
Media contact
David Whitrap
857-523-1219
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$62.10 |
Daily Change: | -0.20 -0.32 |
Daily Volume: | 26,827,464 |
Market Cap: | US$78.870B |
July 10, 2025 February 17, 2025 February 12, 2025 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load